+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aptamers Market - Global Forecast 2026-2030- Product Image
Aptamers Market - Global Forecast 2026-2030- Product Image
New

Aptamers Market - Global Forecast 2026-2030

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904654
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aptamers market is undergoing significant transformation, driven by advancements that streamline diagnostics, therapeutics, and molecular research across the life sciences industry. Senior decision-makers can accelerate innovation and gain a competitive edge by leveraging data-driven insights to align their strategies with evolving market dynamics.

Market Snapshot: Aptamers Market Growth and Trends

The Aptamers Market expanded from USD 254.35 million in 2024 to USD 285.51 million in 2025 and is projected to reach USD 513.77 million by 2030. This progress represents a robust compound annual growth rate (CAGR) of 12.43%. Increasing demand for precise diagnostics and cutting-edge therapies is fueling adoption, favoring solutions that provide high specificity and cost advantages over traditional molecules. Aptamer-based products are increasingly seen as both competitors and complements to established antibody technologies. Rapid innovation in selection protocols and productive international cooperation are positioning aptamer applications for greater uptake across core segments, including biomedical research and clinical diagnostics.

Scope & Segmentation: Drivers Shaping the Aptamers Market

  • Types: The market includes nucleic acid aptamers (from DNA or RNA) and peptide aptamers, which are valued for features such as fast synthesis, molecular stability, and a flexible range of modification options that support various research and development needs.
  • Technologies: Central to market development are multiple selection methodologies, including SELEX (Systematic Evolution of Ligands by Exponential Enrichment), along with specialized variants like capillary electrophoresis-SELEX, microfluidic SELEX, graphene oxide-SELEX, capture-SELEX, cell-SELEX, and computational or hybrid microfluidic systems, all supporting high-throughput candidate discovery for commercial applications.
  • Applications: Aptamers are deployed in clinical diagnostics for cardiovascular, metabolic, infectious, neurological, and oncology settings. Additionally, they play roles in food safety, environmental monitoring, contaminant analysis, therapeutics, and drug development, reflecting their versatility in life sciences workflows.
  • End Users: Key stakeholders include academic and research institutions, hospital and clinical laboratories, and pharmaceutical and biotechnology firms. Each group brings specific drivers for adoption, unique procurement processes, and specialized technical requirements.
  • Regions: The market’s footprint extends across the Americas, Europe, Middle East, Africa, and Asia Pacific. Diverse regulatory climates, infrastructure profiles, and R&D capabilities in each region actively influence innovation, product rollouts, and user adoption.

Aptamers Market: Key Takeaways for Strategic Stakeholders

  • Broader adoption of high-throughput SELEX and advanced computational approaches is streamlining the discovery of aptamers, supporting greater accuracy and faster delivery of binding molecules for varied targets.
  • Integration of aptamer platforms with microfluidic and nanomaterial innovations is improving detection sensitivity, enabling the development of multiplexed and portable test systems adaptable for both laboratory and point-of-care use.
  • Collaboration between technology providers, contract research organizations, and manufacturers is enhancing the transition from development to commercialization, helping to unlock new markets and diversify service offerings.
  • Regional strategies must address variable infrastructure quality, differing public health requirements, and complex regulatory environments with adaptive compliance, localization, and product management plans.
  • Growth in precision medicine, wearable diagnostics, and advanced monitoring for food and environmental safety is expanding aptamer use beyond traditional research boundaries, fueling relevance in emerging sectors.
  • Strong intellectual property management and adaptable design frameworks are essential for organizations to rapidly respond to new technologies and changing market demands.

Tariff Impact on Global Supply Chains and Collaboration

The implementation of United States tariffs in 2025 has resulted in revised global supply strategies for aptamer-focused organizations. Market participants are emphasizing regional manufacturing, expanding supplier diversity, and improving local inventory management. These efforts foster more cohesive international partnerships and support distributed research models that are resilient to trade disruptions. New alliances are developing in regions with favorable trade and regulatory environments, while firms are enhancing operational processes and investing in local production centers. This ensures continuity in aptamer research, manufacturing, and market delivery even under shifting global trade policies.

Research Methodology & Data Sources

This report utilizes extensive literature and patent reviews, up-to-date technical publications, and expert interviews from both industry and regulatory spheres. Supplementary data triangulation was achieved with financial disclosures and regional policy assessment. Supplier evaluation focused on infrastructure and operational resources to deliver a balanced view for leadership decision-making.

Why This Report Matters: Insights for Senior Decision Makers

  • Enables a thorough understanding of foundational aptamer technology drivers and adoption patterns, guiding strategic planning in light of scientific and regulatory changes.
  • Highlights risk management practices, such as building a robust and diversified supplier network and reinforcing operational flexibility responsive to regional shifts.
  • Delivers actionable segment-level analysis that supports effective resource prioritization, fosters industry partnerships, and identifies innovative growth opportunities across priority applications.

Conclusion

The aptamers market is being shaped by ongoing innovation, strong collaborations, and evolving supply approaches. Strategic insights from this report equip leaders to position their organizations for continuous advancement and resilience in dynamic life sciences markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Aptamers Market, by Type
8.1. Nucleic Acid Aptamers
8.1.1. DNA Aptamers
8.1.2. RNA Aptamers
8.2. Peptide Aptamers
9. Aptamers Market, by Technology
9.1. Non-SELEX-Based Technologies
9.2. SELEX Technology
9.2.1. Capillary Electrophoresis (CE)-SELEX
9.2.2. Capture-SELEX
9.2.3. Cell-SELEX
9.2.4. Graphene Oxide (GO)-SELEX
9.2.5. Microfluidic SELEX
9.2.6. Standard SELEX
10. Aptamers Market, by Application
10.1. Clinical Diagnostics
10.1.1. Cardiovascular & Metabolic Disease Diagnostics
10.1.2. Genetic & Rare Disease Screening
10.1.3. Infectious Disease Diagnostics
10.1.4. Neurological Disorder Diagnostics
10.1.5. Oncology Diagnostics
10.2. Food & Environmental Safety
10.2.1. Agricultural Testing
10.2.2. Environmental Monitoring
10.2.3. Food Safety Testing
10.3. Therapeutics & Drug Development
10.3.1. Cardiovascular Diseases
10.3.2. Infectious Diseases
10.3.3. Neurological Disorders
10.3.4. Oncology
10.3.5. Rare & Genetic Disorders
11. Aptamers Market, by End-User
11.1. Academic & Research Institutions
11.2. Hospital & Clinics
11.3. Pharmaceutical & Biotechnology Companies
12. Aptamers Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Aptamers Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Aptamers Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Aptamers Market
16. China Aptamers Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2024
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2024
17.3. Product Portfolio Analysis, 2024
17.4. Benchmarking Analysis, 2024
17.5. 2bind GmbH
17.6. Agilent Technologies, Inc.
17.7. Aptadel Therapeutics SL
17.8. Aptagen, LLC
17.9. AptaMatrix, Inc.
17.10. Aptamer Group PLC
17.11. AptaTargets SL
17.12. AptusBiotech
17.13. Astellas Pharma Inc.
17.14. Base Pair Biotechnologies, Inc.
17.15. Basking Biosciences
17.16. Bio-Techne Corporation
17.17. Biogenes Technologies Sdn. Bhd.
17.18. Biotage
17.19. Cage Bio, Inc.
17.20. Creative Biogene
17.21. Creative Biolabs
17.22. Drive Therapeutics, LLC
17.23. F. Hoffmann-La Roche AG
17.24. Kaneka Eurogentec S.A.
17.25. NEC Corporation
17.26. NeoVentures Biotechnology Inc.
17.27. NOVAPTECH, S.A.S.
17.28. Profacgen
17.29. SomaLogic, Inc.
17.30. TAGCyx Biotechnologies, Inc.
17.31. Veraptus
17.32. Vivonics Inc.
17.33. Zentek Ltd.
List of Figures
FIGURE 1. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 2. GLOBAL APTAMERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL APTAMERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 5. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 11. UNITED STATES APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 12. CHINA APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
List of Tables
TABLE 1. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 2. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 3. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 6. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 22. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 23. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 24. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 25. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 26. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 27. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 28. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 29. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 30. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 31. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 32. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 33. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 34. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 35. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 36. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 37. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 38. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 39. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 40. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 41. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 42. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 43. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 44. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 45. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 46. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 47. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 48. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 49. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 50. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 51. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 52. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 53. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 54. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 55. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 56. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 57. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 58. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 59. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 60. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 61. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 62. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 63. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 64. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 65. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 66. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 67. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 68. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 69. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 70. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 71. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 72. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 73. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 74. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 75. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 76. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 77. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 78. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 79. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 80. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 81. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 82. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 83. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 84. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 85. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 86. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 87. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 88. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 89. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 90. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 91. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 92. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 93. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 94. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 95. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 96. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 97. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 98. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 99. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 100. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 101. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 102. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 103. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 104. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 105. AMERICAS APTAMERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD THOUSAND)
TABLE 106. AMERICAS APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 107. AMERICAS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 108. AMERICAS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 109. AMERICAS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 110. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 111. AMERICAS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 112. AMERICAS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 113. AMERICAS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 114. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 115. NORTH AMERICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 116. NORTH AMERICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 117. NORTH AMERICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 118. NORTH AMERICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 119. NORTH AMERICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 120. NORTH AMERICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 121. NORTH AMERICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 122. NORTH AMERICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 123. NORTH AMERICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 124. NORTH AMERICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 125. LATIN AMERICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 126. LATIN AMERICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 127. LATIN AMERICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 128. LATIN AMERICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 129. LATIN AMERICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 130. LATIN AMERICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 131. LATIN AMERICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 132. LATIN AMERICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 133. LATIN AMERICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 134. LATIN AMERICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD THOUSAND)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 145. EUROPE APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 146. EUROPE APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 147. EUROPE APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 148. EUROPE APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 149. EUROPE APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 150. EUROPE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 151. EUROPE APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 152. EUROPE APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 153. EUROPE APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 154. EUROPE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 155. MIDDLE EAST APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 156. MIDDLE EAST APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 157. MIDDLE EAST APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 158. MIDDLE EAST APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 159. MIDDLE EAST APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 160. MIDDLE EAST APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 161. MIDDLE EAST APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 162. MIDDLE EAST APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 163. MIDDLE EAST APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 164. MIDDLE EAST APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 165. AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 166. AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 167. AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 168. AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 169. AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 170. AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 171. AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 172. AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 173. AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 174. AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 175. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 176. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 177. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 178. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 179. ASIA-PACIFIC APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 180. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 181. ASIA-PACIFIC APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 182. ASIA-PACIFIC APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 183. ASIA-PACIFIC APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 184. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 185. GLOBAL APTAMERS MARKET SIZE, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 186. ASEAN APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 187. ASEAN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 188. ASEAN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 189. ASEAN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 190. ASEAN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 191. ASEAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 192. ASEAN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 193. ASEAN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 194. ASEAN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 195. ASEAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 196. GCC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 197. GCC APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 198. GCC APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 199. GCC APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 200. GCC APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 201. GCC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 202. GCC APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 203. GCC APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 204. GCC APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 205. GCC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 206. EUROPEAN UNION APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 207. EUROPEAN UNION APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 208. EUROPEAN UNION APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 209. EUROPEAN UNION APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 210. EUROPEAN UNION APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 211. EUROPEAN UNION APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 212. EUROPEAN UNION APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 213. EUROPEAN UNION APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 214. EUROPEAN UNION APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 215. EUROPEAN UNION APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 216. BRICS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 217. BRICS APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 218. BRICS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 219. BRICS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 220. BRICS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 221. BRICS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 222. BRICS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 223. BRICS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 224. BRICS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 225. BRICS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 226. G7 APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 227. G7 APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 228. G7 APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 229. G7 APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 230. G7 APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 231. G7 APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 232. G7 APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 233. G7 APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 234. G7 APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 235. G7 APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 236. NATO APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 237. NATO APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 238. NATO APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 239. NATO APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 240. NATO APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 241. NATO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 242. NATO APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 243. NATO APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 244. NATO APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 245. NATO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 246. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 247. UNITED STATES APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 248. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 249. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 250. UNITED STATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 251. UNITED STATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 252. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 253. UNITED STATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 254. UNITED STATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 255. UNITED STATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 256. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 257. CHINA APTAMERS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 258. CHINA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
TABLE 259. CHINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD THOUSAND)
TABLE 260. CHINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 261. CHINA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD THOUSAND)
TABLE 262. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 263. CHINA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD THOUSAND)
TABLE 264. CHINA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD THOUSAND)
TABLE 265. CHINA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD THOUSAND)
TABLE 266. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)

Companies Mentioned

The key companies profiled in this Aptamers market report include:
  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptadel Therapeutics SL
  • Aptagen, LLC
  • AptaMatrix, Inc.
  • Aptamer Group PLC
  • AptaTargets SL
  • AptusBiotech
  • Astellas Pharma Inc.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Bio-Techne Corporation
  • Biogenes Technologies Sdn. Bhd.
  • Biotage
  • Cage Bio, Inc.
  • Creative Biogene
  • Creative Biolabs
  • Drive Therapeutics, LLC
  • F. Hoffmann-La Roche AG
  • Kaneka Eurogentec S.A.
  • NEC Corporation
  • NeoVentures Biotechnology Inc.
  • NOVAPTECH, S.A.S.
  • Profacgen
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies, Inc.
  • Veraptus
  • Vivonics Inc.
  • Zentek Ltd.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 285.51 Million
Forecasted Market Value ( USD ) by 2030 $ 513.77 Million
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Aptamers Market Report 2025 - Product Image

Aptamers Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Aptamers - Global Strategic Business Report - Product Image

Aptamers - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Oligonucleotide Aptamer Market - Global Forecast 2026-2032 - Product Image

Oligonucleotide Aptamer Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F - Product Image

Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F

  • Report
  • 188 Pages
  • Global
From
Aptamers Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Aptamers Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Market

The Aptamer market is a subset of the biotechnology industry that focuses on the development and production of aptamers, which are short, single-stranded DNA or RNA molecules that can bind to specific targets. Aptamers are used in a variety of applications, including diagnostics, therapeutics, and research. Aptamers are often used as alternatives to antibodies, as they are more stable, easier to produce, and can be tailored to bind to a wide range of targets. Aptamers are produced through a process called SELEX (Systematic Evolution of Ligands by Exponential Enrichment), which involves iterative cycles of selection and amplification of aptamers that bind to the desired target. This process is often automated, allowing for the rapid production of aptamers. The Aptamer market is growing rapidly, driven by increasing demand for aptamers in research and clinical applications. Companies in the Aptamer market include Aptagen, Aptamer Solutions, Base Pair Biotechnologies, and Aptamer Group. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.